CD47 expression was correlated with lymph node metastasis, clinical stage, and differentiation degree (P < 0.05), suggesting that as the disease progresses, CD47 expression increases. This evidence concerns the gene CD47 and metastatic malignant neoplasm in the lymph nodes.